Skip to main content
padlock icon - secure page this page is secure
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.

The aim of this journal is to publish timely in-depth reviews as well as original papers in the field of signal transduction therapy. Thematic issues will also be published to cover selected areas of signal transduction therapy. Coverage of the field will include genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases.

Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.

Publisher: Bentham Science Publishers

Volume 12, Number 1, April 2017

Articles

Free Content Graphical Abstracts
pp. i-1v(1)

Favourites:
ADD

Free Content Meet Our Co-Editor
pp. 1-1(1)
Author: Li, Min

Favourites:
ADD
Favourites:
ADD

Molecular Switch of AhR in Repression or Activation of Stem Cell Signaling
pp. 28-33(6)
Authors: Xie, Yingqiu; Zhang, Xiuqing; Atazhanova, Tomiris; Song, Bindong; Yang, Qing

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Pretreatment Serum Fibrinogen Levels are Associated with Postoperative Distant Metastasis and Prognosis of Resected Lung Cancer Patient: A Retrospective Study
pp. 49-57(9)
Authors: Nesa, Effat Un; Shahbaz, Muhammad; Wang, Cong; Zhang, Han; Y. Liu, Xiao; Sun, Ying; Jingyi, Li; Ijaz, Muhammad; Khanam, Tamanna; X. Chen, Peng; Cheng, Yufeng

Favourites:
ADD

System Study of Vascular Smooth Muscle Cell (VSMC) Activation-Related Signaling Pathways by Monocyte and Macrophage Cells
pp. 58-65(8)
Authors: Khosravi, Mohsen; R. Hosseini-Fard, Seyed; Najafi, Mohammad

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more